Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
Clinical trial NCT00226460 · COMPLETED
Trial details
- NCT number
- NCT00226460
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1997-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.